The incidence of fatal breast cancer measures the increased effectiveness of therapy in women participating in mammography screening

Women and their health care providers need a reliable answer to this important question: If a woman chooses to participate in regular mammography screening, then how much will this choice improve her chances of avoiding a death from breast cancer compared with women who choose not to participate?

[1]  Håkan Jonsson,et al.  The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Observational Studies , 2012, Journal of medical screening.

[2]  Rochelle Fu,et al.  Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation , 2016, Annals of Internal Medicine.

[3]  L. Tabár,et al.  REDUCTION IN MORTALITY FROM BREAST CANCER AFTER MASS SCREENING WITH MAMMOGRAPHY Randomised Trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare , 1985, The Lancet.

[4]  P. Rosenberg,et al.  Trends in the Incidence of Fatal Prostate Cancer in the United States by Race. , 2017, European urology.

[5]  L. Tabár,et al.  Swedish two-county trial: impact of mammographic screening on breast cancer mortality during 3 decades. , 2011, Radiology.

[6]  L. Nyström,et al.  Service screening with mammography in Northern Sweden: effects on breast cancer mortality – an update , 2007, Journal of medical screening.

[7]  P. Autier,et al.  Mammography screening: A major issue in medicine. , 2018, European journal of cancer.

[8]  Oguzhan Alagoz,et al.  Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012 , 2018, JAMA.

[9]  H. Joensuu,et al.  Factors predicting late mortality from breast cancer. , 1991, European journal of cancer.

[10]  Philippe Autier,et al.  Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database , 2011, BMJ : British Medical Journal.

[11]  Gregory Doyle,et al.  Pan-Canadian study of mammography screening and mortality from breast cancer. , 2014, Journal of the National Cancer Institute.

[12]  Hsiu-Hsi Chen.  Contributions of Screening and Treatment to Mortality From Breast Cancer. , 2018, JAMA.

[13]  H. Joensuu,et al.  Late mortality from pT1N0M0 breast carcinoma , 1999, Cancer.

[14]  Eugenio Paci,et al.  Breast Cancer Mortality in Mammographic Screening in Europe: A Review of Incidence-Based Mortality Studies , 2012, Journal of medical screening.

[15]  Rhian Gabe,et al.  The randomized trials of breast cancer screening: what have we learned? , 2004, Radiologic clinics of North America.

[16]  L. Nyström,et al.  Service screening with mammography of women aged 50–69 years in Sweden: effects on mortality from breast cancer , 2001, Journal of medical screening.

[17]  King-Jen Chang,et al.  Population-Based Breast Cancer Screening With Risk-Based and Universal Mammography Screening Compared With Clinical Breast Examination: A Propensity Score Analysis of 1 429 890 Taiwanese Women. , 2016, JAMA oncology.

[18]  P. Prorok,et al.  Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness. , 2016, The New England journal of medicine.

[19]  H. Welch.  Screening mammography--a long run for a short slide? , 2010, The New England journal of medicine.

[20]  Richard J. K. Taylor,et al.  Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999–2011 , 2017, British Journal of Cancer.

[21]  L. Nyström.  The Swedish randomised controlled trial on mammography screening has been properly designed, conducted and analysed , 2015, Journal of the Royal Society of Medicine.

[22]  L. Tabár,et al.  Insights from the Breast Cancer Screening Trials: How Screening Affects the Natural History of Breast Cancer and Implications for Evaluating Service Screening Programs , 2015, The breast journal.

[23]  L. Tabár,et al.  Correcting for non‐compliance bias in case–control studies to evaluate cancer screening programmes , 2002 .

[24]  L. Tabár,et al.  Real and artificial controversies in breast cancer screening , 2013 .

[25]  Jay Parikh,et al.  Impact of mammography detection on the course of breast cancer in women aged 40-49 years. , 2012, Radiology.

[26]  M Broeders,et al.  The Impact of Mammographic Screening on Breast Cancer Mortality in Europe: A Review of Trend Studies , 2012, Journal of medical screening.

[27]  D. Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.

[28]  D. Kopans.  The Breast Cancer Screening "Arcade" and the "Whack-A-Mole" Efforts to Reduce Access to Screening. , 2018, Seminars in ultrasound, CT, and MR.

[29]  L. Tabár,et al.  Effect of Mammography Screening on Mortality by Histological Grade , 2017, Cancer Epidemiology, Biomarkers & Prevention.

[30]  Breast cancer mortality in relation to receipt of screening mammography: a case–control study in Saskatchewan, Canada , 2015, Cancer Causes & Control.

[31]  C. Hamashima,et al.  Clarifying the debate on population-based screening for breast cancer with mammography , 2017, Medicine.